SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-028538
Filing Date
2022-11-07
Accepted
2022-11-07 07:37:23
Documents
74
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avtx-20220930.htm   iXBRL 10-Q 1406216
2 EX-10.1 ex-101_apollolicenseagreem.htm EX-10.1 417560
3 EX-10.3 ex-103_apaxestherapeutics.htm EX-10.3 224528
4 EX-31.1 ex311avtx3q2022.htm EX-31.1 11663
5 EX-31.2 ex-312avtx3q2022.htm EX-31.2 11552
6 EX-32.1 ex-321avtx3q2022.htm EX-32.1 10114
12 GRAPHIC avtx-20220930_g1.jpg GRAPHIC 677848
  Complete submission text file 0001628280-22-028538.txt   9785896

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20220930.xsd EX-101.SCH 56269
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avtx-20220930_cal.xml EX-101.CAL 67919
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avtx-20220930_def.xml EX-101.DEF 344709
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20220930_lab.xml EX-101.LAB 696493
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20220930_pre.xml EX-101.PRE 469238
68 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20220930_htm.xml XML 1207093
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 221363753
SIC: 2834 Pharmaceutical Preparations